Core Viewpoint - Earth Science Tech, Inc. has achieved significant growth and operational optimization in the fiscal year ending March 31, 2025, with a focus on value creation through strategic acquisitions and management of its subsidiaries [1][2]. Financial Performance - The company is projected to achieve a net income of $3.6 million, representing a 340% increase year-over-year [3]. - Projected revenue for the fiscal year is expected to surpass $32 million, indicating a 175% increase compared to the previous year [3]. - Earnings per share (EPS) are projected to be $0.01, reflecting strong profitability across the company's operations [3]. Financial Position - Total assets are projected to increase to $7.2 million, marking an 85% growth from the prior fiscal year [4]. - This growth is attributed to both the intrinsic expansion of subsidiaries and strategic capital deployment [4]. Strategic Progress - The fiscal year was characterized by a focus on optimizing operational frameworks to support sustainable growth [5]. - Enhanced governance and cross-subsidiary synergies have been established to drive long-term value [5]. Highlights of FY Ending March 31, 2025 - The Board of Directors expanded to 7 members, including 2 independent members [6]. - The company has qualified for listing on the new OTCID market starting July 2025 [6]. - Employee count increased to 76, up from 42 a year ago, indicating growth in operational capacity [6]. - The company repurchased a total of 20,834,214 common shares under its repurchase program, costing $1,830,617.71 [6]. - Subsidiaries like RxCompoundStore and Peaks Curative have shown significant revenue growth and expansion in product offerings [6]. Future Outlook - The company aims to identify promising ventures and strengthen operational foundations while pursuing innovation for measurable value [7]. - A healthy balance sheet and proven management provide confidence as the company enters the new fiscal year [7].